Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part I--Anticardiolipin and anti-β2-glycoprotein I antibodies

Seminars in Thrombosis and Hemostasis
Emmanuel J FavaloroRichard C W Wong

Abstract

Over 30 years since it was first described as a discrete clinical entity, the antiphospholipid antibody syndrome (APS) remains a challenge for both laboratory workers and clinicians in a wide range of specialties. In addition to the presence of appropriate clinical features, the diagnosis of APS also fundamentally requires the finding of positive antiphospholipid antibody (aPL) test result(s), which comprise clot-based assays for the identification of lupus anticoagulant (LA) and immunologic ("solid-phase") assays such as anticardiolipin antibodies (aCL) and anti-β2-glycoprotein I antibodies (aβ2GPI). This article is the first of two that review the process for, and provides recommendations to improve, internal quality control (IQC) and external quality assurance (EQA; or proficiency testing) for aPL assays. These processes are critical for ensuring the quality of laboratory test results and thence the appropriate clinical diagnosis and management of APS. This article covers aCL and aβ2GPI testing. In brief, IQC is a process that helps control the quality of laboratory test results on a test-by-test basis; IQC should include samples that provide values around the assay critical cut-off values, and there is added value in the in...Continue Reading

Citations

Feb 20, 2015·Hematology·Steven A Krilis, Bill Giannakopoulos
Jul 6, 2016·Clinical Reviews in Allergy & Immunology·Steven R Binder, Christine M Litwin
Mar 14, 2018·Journal of Thrombosis and Haemostasis : JTH·K M J DevreeseUNKNOWN Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
May 25, 2018·Platelets·Emmanuel J Favaloro, Roslyn Bonar
Jan 13, 2018·Nature Reviews. Disease Primers·Karen SchreiberBeverley J Hunt
Apr 18, 2013·International Journal of Laboratory Hematology·E J Favaloro
Apr 23, 2014·International Journal of Laboratory Hematology·K M J Devreese
Oct 18, 2012·Clinical Chemistry and Laboratory Medicine : CCLM·Emmanuel J Favaloro
Nov 2, 2016·Clinical Chemistry and Laboratory Medicine : CCLM·Markus A ThalerPeter B Luppa
Aug 26, 2014·Clinical Chemistry and Laboratory Medicine : CCLM·Paul FroomMira Barak
Aug 14, 2013·Clinical Chemistry and Laboratory Medicine : CCLM·Emmanuel J Favaloro
Jun 21, 2020·Current Rheumatology Reports·Katrien M J Devreese
Nov 5, 2016·Journal of Thrombosis and Haemostasis : JTH·K M DevreeseP Fontana
Sep 14, 2019·Journal of Thrombosis and Haemostasis : JTH·Walid ChayouaKatrien M J Devreese
Jul 27, 2018·Research and Practice in Thrombosis and Haemostasis·Karel Maelegheer, Katrien M J Devreese
Jun 17, 2020·International Journal of Laboratory Hematology·Katrien M J Devreese
May 23, 2021·Thrombosis Research·Romy M W de Laat-KremersBas de Laat

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.